ECM
PGNX

Everence Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Everence Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
2020
Q2 		$123K Hold
2020
Q1 		$110K Hold
2019
Q4 		$148K Hold
2019
Q3 		$146K Hold
2019
Q2 		$179K Hold
2019
Q1 		$134K Buy